MRI Interventions’ ClearPoint System Facilitates Asleep DBS Surgery at San Francisco VA Medical Center for Veterans with Parkinson’s Disease

Researchers at University of California, San Francisco and National Institutes of Health have begun a Phase I clinical study utilizing MRI Intervention’s ClearPoint System to enable direct infusion of a gene therapy, glial cell line-derived neurotrophic factor (GDNF), into an area of the brain affected by Parkinson’s disease. Read more…